Literature DB >> 22075781

Mechanisms underlying and medical management of L-Dopa-associated motor complications.

Manfred Gerlach, Peter Riederer, Dieter Scheller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22075781     DOI： 10.1007/s00702-011-0728-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


× No keyword cloud information.
  11 in total

1.  Flibanserin attenuates L: -DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Authors:  Manfred Gerlach; Jürgen Beck; Peter Riederer; Maarten van den Buuse
Journal:  J Neural Transm (Vienna)       Date:  2011-01-28       Impact factor: 3.575

2.  Transcriptional alterations under continuous or pulsatile dopaminergic treatment in dyskinetic rats.

Authors:  E Grünblatt; W J Schmidt; D K A Scheller; P Riederer; M Gerlach
Journal:  J Neural Transm (Vienna)       Date:  2010-12-25       Impact factor: 3.575

Review 3.  Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression.

Authors:  P Jenner; A C McCreary; D K A Scheller
Journal:  J Neural Transm (Vienna)       Date:  2011-09-01       Impact factor: 3.575

Review 4.  Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.

Authors:  Mahmoud M Iravani; Peter Jenner
Journal:  J Neural Transm (Vienna)       Date:  2011-09-01       Impact factor: 3.575

Review 5.  The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease.

Authors:  T N Chase
Journal:  Drugs       Date:  1998       Impact factor: 9.546

Review 6.  Rotigotine transdermal patch for the treatment of Parkinson's disease and restless legs syndrome.

Authors:  B Boroojerdi; H-M Wolff; M Braun; D K A Scheller
Journal:  Drugs Today (Barc)       Date:  2010-07       Impact factor: 2.245

7.  Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on L: -DOPA-induced dyskinesia.

Authors:  Andrzej Dekundy; Andreas Gravius; Mirko Hechenberger; Małgorzata Pietraszek; Jens Nagel; Carsten Tober; Martine van der Elst; Flora Mela; Christopher G Parsons; Wojciech Danysz
Journal:  J Neural Transm (Vienna)       Date:  2010-12-16       Impact factor: 3.575

Review 8.  Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations.

Authors:  Joseph Jankovic
Journal:  Mov Disord       Date:  2005       Impact factor: 10.338

Review 9.  Levodopa, motor fluctuations and dyskinesia in Parkinson's disease.

Authors:  Thomas Müller; Hermann Russ
Journal:  Expert Opin Pharmacother       Date:  2006-09       Impact factor: 3.889

10.  Long-term antidyskinetic efficacy of amantadine in Parkinson's disease.

Authors:  Elisabeth Wolf; Klaus Seppi; Regina Katzenschlager; Guenter Hochschorner; Gerhard Ransmayr; Petra Schwingenschuh; Erwin Ott; Iris Kloiber; Dietrich Haubenberger; Eduard Auff; Werner Poewe
Journal:  Mov Disord       Date:  2010-07-30       Impact factor: 10.338
View more
  6 in total

1.  The effect of piribedil on L-DOPA-induced dyskinesias in a rat model of Parkinson's disease: differential role of α(2) adrenergic mechanisms.

Authors:  Manfred Gerlach; Paul Halley; Peter Riederer; Maarten van den Buuse
Journal:  J Neural Transm (Vienna)       Date:  2012-05-17       Impact factor: 3.575

2.  Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.

Authors:  P A Broderick; L Wenning; Y-S Li
Journal:  J Neural Transm (Vienna)       Date:  2016-10-28       Impact factor: 3.575

Review 3.  Beyond muscles: The untapped potential of creatine.

Authors:  Lisa A Riesberg; Stephanie A Weed; Thomas L McDonald; Joan M Eckerson; Kristen M Drescher
Journal:  Int Immunopharmacol       Date:  2016-01-08       Impact factor: 4.932

4.  Pramipexole-induced limb dystonia and its associated complex regional pain syndrome in idiopathic Parkinson's disease: A case report.

Authors:  Donghwi Park
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

Review 5.  Neuroleptic malignant syndrome: an easily overlooked neurologic emergency.

Authors:  Ramadhan Oruch; Ian F Pryme; Bernt A Engelsen; Anders Lund
Journal:  Neuropsychiatr Dis Treat       Date:  2017-01-16       Impact factor: 2.570

6.  Biological sources of inflexibility in brain and behavior with aging and neurodegenerative diseases.

Authors:  S Lee Hong; George V Rebec
Journal:  Front Syst Neurosci       Date:  2012-11-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.